Stocks · NASDAQ · Healthcare · United States
MRNA — Moderna, Inc.
Moderna, Inc. (MRNA) is a healthcare stock listed on NASDAQ (United States). At the close of September 29, 2026 it traded at 203.46 (+3.13% on the day), +45.0% over one month, +180.6% over three months, +703.2% over twelve months. The InvestMuse composite score is +20 on a −100 to +100 scale, a mixed read that ranks #594 of about 1,221 assets. The strongest of its nine dimensions are Trend (+100) and Momentum (+100); the weakest is Sector edge (-100). Its volatility regime from the hidden Markov model is Calm. 154 news articles in the last 30 days carried an average tone of +0.21 (on −1 to +1).
The facts
| Last close | 203.46 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | +3.13% / +45.0% / +180.6% / +703.2% |
| 52-week range | 22.36 – 203.46 |
| Composite score | +20 / 100 · mixed view · rank #594 |
| Volatility regime (HMM) | Calm |
| Market cap | $27.7B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)+75
- Technical indicators-38
- Trend+100
- Support / resistance0
- Fundamentals-37
- Sector edge-100
- News sentiment+22
- Momentum+100
- Chart patterns and zones+53
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.